Latest News

  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.

    Sep 25, 2025

  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.

    Sep 25, 2025

  • Follow the Money: Blood-Based Ovarian Cancer Test, Esophageal Diagnostic Platform, More

    Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.

    Sep 24, 2025

  • Apple Watch Receives FDA Clearance for Hypertension Notifications

    Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected.

    Sep 18, 2025

  • Biomarker Combo Could Guide Treatment of Recurring Ovarian Cancer

    Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.

    Sep 17, 2025

  • AI-Stethoscope Increases Cardiac Condition Diagnoses in Routine Care

    Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.

    Sep 16, 2025

  • Qure.ai Scans Routine Chest X-Rays for Early Cancer Diagnoses

    Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.

    Sep 11, 2025